Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Significant Features of DNA Methylation at Bivalent Promotor and Repressed Polycomb Regions in Pediatric AML-the Jccg Study, JPLSG AML-05-

Blood (2019) 134 (Supplement_1): 2739.

https://doi.org/10.1182/blood-2019-125025

Published: 2019

Journal Articles

Lck Is a Crucial Anergy Regulator in CLL

Alexander Fuchs, Melanie Märklin, PhD, Jonas Heitmann, Felicia Truckenmüller, Sebastian Jonas Saur, MD, Manuela Ganser, Stefanie Bugl, Ursula Kohlhofer, Leticia Quintanilla-Martinez, MD, Hans-Georg Kopp, MD, Lothar Kanz, Anjana Rao, PhD, Stefan Wirths, MD, Martin R. Mueller, MD PhD

Blood (2017) 130 (Supplement 1): 3003.

https://doi.org/10.1182/blood.V130.Suppl_1.3003.3003

Published: 2017

Journal Articles

Oncogenic Feedback Activation Between BCL6 and MLL Promotes Malignant Transformation in MLL -RearrangedAcute Lymphoblastic Leukemia

Christian Hurtz, PhD, Lai N Chan, PhD, Erica Ballabio, MD, Cheryl L. Willman, William L. Carroll, MD, Scott A. Armstrong, MD PhD, Patricia Ernst, PhD, Ari Melnick, MD, Thomas Milne, PhD, Markus Müschen, MD PhD

Blood (2016) 128 (22): 907.

https://doi.org/10.1182/blood.V128.22.907.907

Published: 2016

Journal Articles

Inhibition of the Epigenetic Modifier EZH2 Upregulates Cell Cycle Control Genes to Inhibit Myeloma Cell Growth and Overcome High-Risk Disease Features

Charlotte Pawlyn, MB BChir, Michael Bright, PhD, Amy Buros, PhD, Caleb K. Stein, MS, Zoe Walters, PhD, Lauren Aronson, PhD, Fabio Mirabella, PhD, Martin F Kaiser, MD, John R Jones, MD, Brian A Walker, PhD, Graham H Jackson, MD PhD, Paul Clarke, PhD, Leif Bergsagel, MD, Paul Workman, PhD, Marta Chesi, PhD, Gareth J Morgan, MD PhD, Faith E Davies, MD

Blood (2016) 128 (22): 3289.

https://doi.org/10.1182/blood.V128.22.3289.3289

Published: 2016

Journal Articles

Rare Case of Alternative Splicing Form Caused By L248V Mutation in CML Patient

Pavel Butylin, PhD, Natalia Matyuhina, MS, Nadia Siordia, MD, Elza Lomaya, MD, Andrey Zaritskey, MD

Blood (2015) 126 (23): 5139.

https://doi.org/10.1182/blood.V126.23.5139.5139

Published: 2015

Journal Articles

NFATc1 Is Transcriptionally Activated in Chronic Lymphocytic Leukemia (CLL) By Promotor DNA-Hypomethylation Which Correlates with in-Vitro Vulnerability to Calcineurin Inhibitors

Christine Wolf, Katharina Filarsky, Angela Garding, PhD, Rainer Claus, MD, Christopher C Oakes, PhD, Irina Idler, PhD, Christoph Plass, PhD, Peter Lichter, PhD, Hartmut Doehner, MD, Stephan Stilgenbauer, MD, Daniel Mertens, PhD

Blood (2014) 124 (21): 1941.

https://doi.org/10.1182/blood.V124.21.1941.1941

Published: 2014

Journal Articles

Epigenetic Silencing of a Novel Candidate Tumor Suppressor “miR” Predicts Poor Prognosis In High-Risk MDS and AML.

Marianne B. Treppendahl, MD, Xiangning Qiu, MD, Christoffer Hother, MD, Mette K. Andersen, MD, PhD, Lars Kjeldsen, MD, PhD, Peter Jones, Professor, Gangning Liang, PhD, Kirsten Gr∅nbæk, MD, PhD

Blood (2010) 116 (21): 3629.

https://doi.org/10.1182/blood.V116.21.3629.3629

Published: 2010

Journal Articles

Impaired Lentiviral Transgene Expression In Vivo Caused by Massive Methylation of SFFV Promoter Sequences.

Friederike Herbst, Claudia R Ball, PhD, Francesca Tuorto, PhD, Wei Wang, Ulrich Kloz, Frank van der Hoeven, Frank Lyko, PhD, Christof Von Kalle, MD, Hanno Glimm, MD

Blood (2010) 116 (21): 3760.

https://doi.org/10.1182/blood.V116.21.3760.3760

Published: 2010

Journal Articles

Facilitation of Osteoblast Differentiation by ATF-4 Accumulation through Proteasome Inhibition.

Shingen Nakamura, Masahiro Abe, Qu Cui, Ayako Nakano, Asuka Oda, Hiroe Amou, Akishige Ikegame, Takeshi Harada, Masahiro Hiasa, Hirokazu Miki, Kumiko Kagawa, Kyoko Takeuchi, Kenichiro Yata, Shuji Ozaki, Toshio Matsumoto

Blood (2009) 114 (22): 1823.

https://doi.org/10.1182/blood.V114.22.1823.1823

Published: 2009

Journal Articles

Concurrent Visualization of Trafficking and NFAT Signalling in Primary T Lymphocytes and T Cell Precursors In Vivo.

Il-Kang Na, MD, John Markley, MD, PhD, Jennifer Tsai, MD, Nury L. Yim, Bradley J. Beattie, Alexander D. Klose, PhD, Amanda M. Holland, Arnab Ghosh, MD, PhD, Uttam K. Rao, Matthias Stephan, MD, PhD, Inna Serganova, PhD, Renier J. Brentjens, MD, PhD, Ron R.G. Blasberg, MD, Michel W Sadelain, MD, PhD, Marcel R.M. van den Brink, MD, PhD

Blood (2009) 114 (22): 914.

https://doi.org/10.1182/blood.V114.22.914.914

Published: 2009

Journal Articles

Physiological Non-Responsiveness and Absence of Activation Induced Cell Death of T Cells Rapidly Re-Expressing Retrovirally Introduced TCRs after T Cell Activation.

Marleen van Loenen, Renate Hagedoorn, Esther van Egmond, Roelof Willemze, J.H. Frederik Falkenburg, Mirjam Heemskerk

Blood (2007) 110 (11): 2301.

https://doi.org/10.1182/blood.V110.11.2301.2301

Published: 2007

Journal Articles

A Heat-Inducible Gene Expression System for a Dominant Negative Version of a TGF-β-Receptor Reveals Antitumor Activity in a Rodent Tumor Model

Fatih Noyan, Ricardo A. Dewey, PhD, Hans H. Kreipe, Joerg Fruehauf, Christoph Klein

Blood (2007) 110 (11): 3742.

https://doi.org/10.1182/blood.V110.11.3742.3742

Published: 2007

Journal Articles

Expression of DNMT Isoforms Is Differentially Associated with Aberrant Promotor Methylation in MDS Hematopoietic Progenitor Cells during Lineage Specific Differentiation.

Olaf J. Hopfer, MD, Martina Komor, PhD, Ina S. Koehler, Matthias Schulze, PhD, Claudia Freitag, Dieter Hoelzer, MD,PhD, Eckhard Thiel, MD,PhD, Wolf-Karsten Hofmann, MD,PhD

Blood (2006) 108 (11): 2628.

https://doi.org/10.1182/blood.V108.11.2628.2628

Published: 2006

Journal Articles

Non-Random Integration and Clone Selection by Lentiviral SIN-LTR Vectors.

Cynthia C. Bartholomae, Annette Deichmann, Manfred Schmidt, PhD, Rafael J. Yanez-Munoz, PhD, Steven J. Howe, PhD, Sonja Schmidt, Claudia Prinz, Adrian J. Thrasher, MD, PhD, Christof von Kalle, MD

Blood (2006) 108 (11): 3257.

https://doi.org/10.1182/blood.V108.11.3257.3257

Published: 2006

Journal Articles

Promotor Demethylation as a Mechanism of HOX11 Activation in Adult T-ALL?.

Ulrike Baak, MD, Helmut Orawa, MA, Nicola Goekbuget, MD, Olaf Hopfer, MD, Thomas Burmeister, MD, Wolf-Karsten Hofmann, MD, Dieter Hoelzer, MD, Eckhard Thiel, MD

Blood (2006) 108 (11): 2288.

https://doi.org/10.1182/blood.V108.11.2288.2288

Published: 2006

Journal Articles

Identification of MDS-Specific and Methylation Associated Downregulation of Survivine and WT1 in Highly Purified Hematopoietic Progenitor Cells during In Vitro Lineage Specific Differentiation.

Olaf J. Hopfer, MD, Martina Komor, MD, Dieter Hoelzer, MD, PhD, Eckhard Thiel, MD, PhD, Wolf-Karsten Hofmann, MD, PhD

Blood (2005) 106 (11): 3442.

https://doi.org/10.1182/blood.V106.11.3442.3442

Published: 2005

Journal Articles

Physiological TCR Modulation after Antigen Specific Triggering of Introduced TCRs under Control of a Retroviral Promotor.

Marleen M. van Loenen, Renate S. Hagedoorn, Esther H.M. van Egmond, Roel Willemze, MD, PhD, J.H.Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD

Blood (2005) 106 (11): 5537.

https://doi.org/10.1182/blood.V106.11.5537.5537

Published: 2005

Journal Articles

Genetic Pathways in t-MDS and t-AML, a Revised Model.

Jens Pedersen-Bjergaard, MD, Ph.D, Debes H. Christiansen, MS, Mette K. Andersen, MD

Blood (2004) 104 (11): 2993.

https://doi.org/10.1182/blood.V104.11.2993.2993

Published: 2004

NARROW

Significant Features of DNA Methylation at Bivalent Promotor and Repressed Polycomb Regions in Pediatric AML-the Jccg Study, JPLSG AML-05-

Lck Is a Crucial Anergy Regulator in CLL

Oncogenic Feedback Activation Between BCL6 and MLL Promotes Malignant Transformation in MLL -RearrangedAcute Lymphoblastic Leukemia

Inhibition of the Epigenetic Modifier EZH2 Upregulates Cell Cycle Control Genes to Inhibit Myeloma Cell Growth and Overcome High-Risk Disease Features

Rare Case of Alternative Splicing Form Caused By L248V Mutation in CML Patient

NFATc1 Is Transcriptionally Activated in Chronic Lymphocytic Leukemia (CLL) By Promotor DNA-Hypomethylation Which Correlates with in-Vitro Vulnerability to Calcineurin Inhibitors

Epigenetic Silencing of a Novel Candidate Tumor Suppressor “miR” Predicts Poor Prognosis In High-Risk MDS and AML.

Impaired Lentiviral Transgene Expression In Vivo Caused by Massive Methylation of SFFV Promoter Sequences.

Facilitation of Osteoblast Differentiation by ATF-4 Accumulation through Proteasome Inhibition.

Concurrent Visualization of Trafficking and NFAT Signalling in Primary T Lymphocytes and T Cell Precursors In Vivo.

Physiological Non-Responsiveness and Absence of Activation Induced Cell Death of T Cells Rapidly Re-Expressing Retrovirally Introduced TCRs after T Cell Activation.

A Heat-Inducible Gene Expression System for a Dominant Negative Version of a TGF-β-Receptor Reveals Antitumor Activity in a Rodent Tumor Model

Expression of DNMT Isoforms Is Differentially Associated with Aberrant Promotor Methylation in MDS Hematopoietic Progenitor Cells during Lineage Specific Differentiation.

Non-Random Integration and Clone Selection by Lentiviral SIN-LTR Vectors.

Promotor Demethylation as a Mechanism of HOX11 Activation in Adult T-ALL?.

Identification of MDS-Specific and Methylation Associated Downregulation of Survivine and WT1 in Highly Purified Hematopoietic Progenitor Cells during In Vitro Lineage Specific Differentiation.

Physiological TCR Modulation after Antigen Specific Triggering of Introduced TCRs under Control of a Retroviral Promotor.

Genetic Pathways in t-MDS and t-AML, a Revised Model.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only